ArticleBMC medical imaging2025
Deep learning-based classification of parotid gland tumors: integrating dynamic contrast-enhanced MRI for enhanced diagnostic accuracy.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deep Learning-Assisted MRI for Differentiating Parotid Gland Tumors: Comparison with FNAB and Radiologic Assessment.Diagnostics (Basel, Switzerland) · 2026Article
- Identification of Syndrome Types in Patients With Pancreatic Cancer From Free Text in Electronic Medical Records: Model Development and Validation.JMIR formative research · 2025Article
- Interpretable Deep Learning Radiomics for Differentiating Pleomorphic Adenoma and Warthin Tumor.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the performance of deep learning models in classifying parotid gland tumors using T2-weighted, diffusion-weighted, and contrast-enhanced T1-weighted MR images, along with DCE data derived from time-intensity curves.
methodsIn this retrospective, single-center study including a total of 164 participants, 124 patients with surgically confirmed parotid gland tumors and 40 individuals with normal parotid glands underwent multiparametric MRI, including DCE sequences. Data partitions were performed at the patient level (80% training, 10% validation, 10% testing). Two deep learning architectures (MobileNetV2 and EfficientNetB0), as well as a combined approach integrating predictions from both models, were fine-tuned using transfer learning to classify (i) normal versus tumor (Task 1), (ii) benign versus malignant tumors (Task 2), and (iii) benign subtypes (Warthin tumor vs. pleomorphic adenoma) (Task 3). For Tasks 2 and 3, DCE-derived metrics were integrated via a support vector machine. Classification performance was assessed using accuracy, precision, recall, and F1-score, with 95% confidence intervals derived via bootstrap resampling.
resultsIn Task 1, EfficientNetB0 achieved the highest accuracy (85%). In Task 2, the combined approach reached an accuracy of 65%, while adding DCE data significantly improved performance, with MobileNetV2 achieving an accuracy of 96%. In Task 3, EfficientNetB0 demonstrated the highest accuracy without DCE data (75%), while including DCE data boosted the combined approach to an accuracy of 89%.
conclusionsAdding DCE-MRI data to deep learning models substantially enhances parotid gland tumor classification accuracy, highlighting the value of functional imaging biomarkers in improving noninvasive diagnostic workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.